Skip to content

Opening book details…

About this Medicine article

A PHASE 2, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP, MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF TACROLIMUS/FK778 AND TACROLIMUS/MMF IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS. by &NA;, is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
&NA;,
Publisher
Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0041-1337)
Published
2006
Language
EN
Field
Medicine (Health Sciences)

More by &NA;,

Browse all works by &NA;,